RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC.vs its industry peers
A metric-by-metric comparison of REVIVA PHARMACEUTICALS HOLDINGS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RVPHEsta | $5M#8 | — | 0.3x#1 | — | — | 33.6%#8 | — | -130.6%#6 | — | — | — | — |
| PRPH | $6M#1 | — | — | 1.3x#3 | -35.8%#7 | 72.4%#3 | -415.4%#4 | — | -804.6%#5 | — | -90.0%#3 | — |
| ACXP | $5M#2 | — | 0.7x#5 | — | — | 43.5%#6 | — | -97.7%#4 | — | — | — | — |
| PULM | $5M#3 | — | 2.1x#11 | 0.7x#2 | 7.0%#5 | 46.0%#5 | -66.2%#1 | -201.9%#7 | -235.7%#3 | — | — | — |
| PCSA | $5M#4 | 2.8x#4 | — | — | — | -14.5%#13 | — | — | — | — | -80.8%#1 | 0.8%#1 |
| IMNN | $5M#5 | — | — | — | — | — | — | — | — | — | — | — |
| TCRT | $5M#6 | — | 7.5x#13 | 973.0x#8 | -50.0%#8 | 10.8%#11 | -84500.0%#8 | -640.5%#13 | — | — | — | — |
| XBIO | $5M#7 | — | 0.8x#6 | 1.6x#5 | 19.0%#4 | 32.3%#9 | -95.2%#3 | -44.1%#3 | -1516.8%#7 | 4#2 | — | — |
| TRAW | $4M#9 | — | 0.4x#4 | 1.6x#4 | 1134.5%#1 | 105.5%#2 | -640.7%#5 | 79.2%#2 | — | — | — | — |
| CVKD | $4M#10 | — | 1.0x#8 | — | — | -24.3%#14 | — | -323.5%#11 | -585.1%#4 | — | — | — |
| ERNA | $3M#11 | 0.0x#2 | 1.1x#9 | 5.9x#7 | 755.9%#2 | 68.4%#4 | -1601.2%#7 | -440.1%#12 | -1016.2%#6 | — | — | — |
| GRI | $3M#12 | — | 0.3x#2 | — | -100.0%#9 | -45.7%#15 | — | -116.3%#5 | — | — | — | — |
| KALA | $3M#13 | 0.0x#1 | 0.4x#3 | — | — | 29.9%#10 | — | -298.3%#10 | -69.9%#1 | — | — | — |
| DRMA | $3M#14 | — | 0.9x#7 | — | — | 38.5%#7 | — | -216.7%#8 | — | — | — | — |
| SXTP | $3M#15 | — | 1.2x#10 | 3.2x#6 | 65.5%#3 | 7.3%#12 | -771.6%#6 | -281.7%#9 | -163.8%#2 | 6#1 | -84.0%#2 | — |
| PTPI | $3M#16 | 0.1x#3 | 3.8x#12 | 0.5x#1 | -12.2%#6 | 113.4%#1 | -90.8%#2 | 273.0%#1 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice